Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation.

Abstract:

BACKGROUND/AIM:This study's aim was to investigate the safety and effectiveness of asunaprevir and daclatasvir treatment for recurrent hepatitis C virus (HCV) infection in transplant recipients. The study cohort comprised 14 transplant recipients with recurrent hepatitis C who were receiving asunaprevir and daclatasvir. PATIENTS AND METHODS:Serum concentrations of asunaprevir and daclatasvir, their therapeutic effects, trough concentrations/dose ratios of tacrolimus, and adverse effects were evaluated. RESULTS:Hepatitis C virus was still undetectable in 12 (85.7%) out of 14 patients 12 weeks after completing treatment. One week after starting treatment, asunaprevir concentrations were significantly higher in patients with baseline albumin concentrations ≤3.6 g/dl than in those with baseline albumin concentrations >3.6 g/dl. No marked fluctuations were identified in tacrolimus trough concentrations/dose ratios during the 24 weeks of therapy. CONCLUSION:Full doses of asunaprevir and daclatasvir-based treatment can be safely and effectively administered to liver transplant recipients for recurrent HCV genotype 1b after living donor liver transplantation (LDLT) with little effect on blood concentrations of tacrolimus.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Harada N,Yoshizumi T,Ikegami T,Itoh S,Furusho N,Kato M,Shimoda S,Fukuhara T,Soejima Y,Maehara Y

doi

10.21873/anticanres.12885

subject

Has Abstract

pub_date

2018-09-01 00:00:00

pages

5513-5520

issue

9

eissn

0250-7005

issn

1791-7530

pii

38/9/5513

journal_volume

38

pub_type

杂志文章
  • Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.

    abstract::The cyclin-dependent kinase inhibitor (CDK1) p27(kip1) is a negative regulator of cell cycling and has antitumor effects. In our previous study, the recombinant adenovirus expressing wild-type p27(kip1) (Adp27-wt) induced cell cycle arrest and apoptosis, and proved that p27 is a tumor suppressor gene like p53. Another...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Shiraso S,Katayose Y,Yamamoto K,Mizuma M,Yabuuchi S,Oda A,Rikiyama T,Onogawa T,Yoshida H,Hayashi H,Ohtsuka H,Motoi F,Egawa S,Kato J,Unno M

    更新日期:2009-06-01 00:00:00

  • Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.

    abstract:BACKGROUND:Chronic lymphocytic leukemia (CLL) is characterized by a clonal accumulation of neoplastic lymphocytes, indicating disruption of apoptosis. PATIENTS AND METHODS:Differential methylation hybridization analysis was performed to identify novel target genes silenced by CpG island methylation in patients with CL...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.10998

    authors: Schmidt-Wolf IG,Plass C,Byrd JC,Frevel K,Pietsch T,Waha A

    更新日期:2016-09-01 00:00:00

  • Effect of ALP analogs on inositol trisphosphate formation in H184 mammary epithelial cells before and after transfection with v-erb B oncogene.

    abstract::The influence of cytostatically active alkyllysophospholipid analogs with different chemical structure on IP3 (inositol-1,4,5-trisphosphate) formation and intracellular Ca++ concentration was studied in human mammary epithelial cells before and after transfection with v-erb B oncogene DNA. Transformed cells showed an ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Junghahn I,Bergmann J,Langen P,Thun I,Vollgraf C,Brachwitz H

    更新日期:1995-03-01 00:00:00

  • Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.

    abstract::Rats were inoculated subcutaneously into both flanks with a transplantable adenocarcinoma of the colon. They were treated intravenously with either 5-FUrd (5-fluorouridine) or 5-FdUrd (5-fluoro-2'-deoxyuridine) with or without addition of dipyridamole 20 and 30 min later, respectively, for 3 consecutive days. Dipyrida...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: el Hag IA,Roos G,Jönsson PE,Stenram U

    更新日期:1990-01-01 00:00:00

  • Role of protein kinase C in the deficient gap junctional intercellular communication of K-ras-transformed murine lung epithelial cells.

    abstract:BACKGROUND:Protein kinase C (PKC) activity is increased and gap junctional intercellular communication (GJIC) is decreased frequently in Ras-transformed cells. We investigated the roles of Ras and PKC in the deficient gap junctional intercellular communication (GJIC) of K-ras-transformed E9 mouse lung carcinoma cells. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cesen-Cummings K,Warner KA,Ruch RJ

    更新日期:1998-11-01 00:00:00

  • Brief Pain Inventory (BPI) Health Survey After Midline Laparotomy With the Rectus Sheath Block (RSB) Analgesia: A Randomised Trial of Patients With Cancer and Benign Disease.

    abstract:BACKGROUND/AIM:Our original hypothesis was that the rectus sheath block (RSB) analgesia could enhance patient satisfaction and decrease pain following midline laparotomy. PATIENTS AND METHODS:Initially, 56 patients were randomized into four groups; control group (n=12), single-dose (n=16), repeated-dose (n=12) and con...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.21873/anticanres.13890

    authors: Kuosmanen V,Ruottinen M,Rahkola D,Saimanen I,Kaaronen V,Selander T,Purdy M,Kokki H,Kokki M,Eskelinen M

    更新日期:2019-12-01 00:00:00

  • Effect of genistein on p90RSK phosphorylation and cell proliferation in T47D breast cancer cells.

    abstract:BACKGROUND:The molecular mechanisms of genistein's proliferative effects on breast cancer cells are largely unknown. This study aimed to examine estrogen-receptor (ER)-related signaling molecules involved in genistein-associated cell proliferation and survival (ERK1/2, p90RSK, JNK, Akt and NFκB) and to correlate these ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gwin J,Drews N,Ali S,Stamschror J,Sorenson M,Rajah TT

    更新日期:2011-01-01 00:00:00

  • Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.

    abstract:BACKGROUND:Glioblastoma multiforme (GBM) remains the most aggressive and frequently occurring brain neoplasm. Members of the Rho family of small GTP-binding proteins, including Rho, Rac, and Cdc42, have been shown to participate in cell growth differentiation and motility. The mitogen-activated protein kinase (MAPK) pa...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zohrabian VM,Forzani B,Chau Z,Murali R,Jhanwar-Uniyal M

    更新日期:2009-01-01 00:00:00

  • Clinical implications of the ISC technique for breast cancer radiotherapy and comparison with clinical recommendations.

    abstract:PURPOSE:The present project studied the implications of using the irregular surface compensator (ISC) technique in comparison to three-dimensional conformal radiation therapy (3D-CRT) for breast cancer treatment. ISC is an electronic compensation algorithm that modulates the fluence across the radiation fields to compe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Flejmer AM,Josefsson D,Nilsson M,Stenmarker M,Dasu A

    更新日期:2014-07-01 00:00:00

  • Differential Mechanism of Action of 3,4',7-O-trimethylquercetin in Three Types of Ovarian Cancer Cells.

    abstract:BACKGROUND/AIM:3,4',7-O-trimethylquercetin (34'7TMQ), a derivative of quercetin, inhibited ovarian cancer cell migration and invasion without affecting proliferation. In this study, the apoptotic effect of 34'7TMQ on three cancer cell lines (CRL-1978, CRL-11731, SK-OV-3) was evaluated. MATERIALS AND METHODS:Expression...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12835

    authors: Ashraf AHMZ,Afroze SH,Yamauchi K,Zawieja DC,Keuhl TJ,Erlandson LW,Uddin MN

    更新日期:2018-09-01 00:00:00

  • Cryosurgery plus adjuvant systemic alpha2-interferon for HPV-associated lesions.

    abstract:OBJECTIVE:The authors report their experience in patients with adjuvant systemic 2-interferon with the aim of defining the effectiveness, side-effects, indications and limitations of this treatment. MATERIALS AND METHODS:From January 1989 to December 1996, 123 patients with genital, anorectal and perineal HPV lesions ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Scala M,Bonelli G,Gipponi M,Margarino G,Muzza A

    更新日期:2002-03-01 00:00:00

  • Macrophage apolipoprotein E and proliferation of MCF-7 breast cancer cells: role of LXR.

    abstract:BACKGROUND:Apolipoprotein E (APOE), a lipid transport protein that has a key role in the lipoprotein metabolism, is expressed by macrophages under the control of the transcription factor Liver X Receptor (LXR), an oxysterol-activated transcriptional factor involved in cholesterol metabolism. Recent work has shown that ...

    journal_title:Anticancer research

    pub_type: 历史文章,杂志文章

    doi:

    authors: El Roz A,Bard JM,Valin S,Huvelin JM,Nazih H

    更新日期:2013-09-01 00:00:00

  • Radiation-induced second malignancies.

    abstract:BACKGROUND:The number of patients with second malignancies is growing and they represent about one in six out of all new cancers. Second malignancies can be categorized into three major groups according to the predominant etiological factor(s): (i) treatment-related, (ii) part of a syndrome and (iii) those due to share...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Mahmood S,Vu K,Tai P,Joseph K,Koul R,Dubey A,Yu E

    更新日期:2015-04-01 00:00:00

  • Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts.

    abstract:BACKGROUND:A critical step in the delivery of nanomedicines to tumour cells is transporting these particles through the extracellular matrix. Tumour-specific anticancer agents, such as encapsulated drugs, proteins, and genes, show low uptake in tumour tissue. It is not clear whether the collagen network or the glycosam...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Eikenes L,Tufto I,Schnell EA,Bjørkøy A,De Lange Davies C

    更新日期:2010-02-01 00:00:00

  • Safety and Efficacy of Carbon-ion Radiotherapy Alone for Stage III Non-small Cell Lung Cancer.

    abstract:BACKGROUND/AIM:We evaluated the efficacy and safety of carbon-ion radiotherapy (CIRT) alone for Stage III non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS:Data of 65 patients (median age=73 years) with Stage III NSCLC who underwent CIRT alone in the QST Hospital, Chiba, Japan, between 1997 and 2015 were retros...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13963

    authors: Anzai M,Yamamoto N,Hayashi K,Nakajima M,Nomoto A,Ogawa K,Tsuji H

    更新日期:2020-01-01 00:00:00

  • Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma.

    abstract:BACKGROUND:In our previous study, it was suggested that nitrotyrosine, a product of nitrogen species, found in esophageal squamous cell carcinoma (ESCC), may contribute to the progression of esophageal cancer. MATERIALS AND METHODS:To clarify whether nitrotyrosine expression is associated with apoptosis and/or angioge...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kato H,Miyazaki T,Yoshikawa M,Nakajima M,Fukai Y,Masuda N,Ojima H,Tsukada K,Nishida Y,Kuwano H

    更新日期:2001-09-01 00:00:00

  • Association between genetic polymorphisms and ovarian cancer risk.

    abstract:BACKGROUND:The etiology of ovarian cancer is not fully understood. Polymorphisms in low penetrance genes involved in carcinogen and estrogen metabolism are hypothesized to play a role in the initiation of carcinogenesis. PATIENTS AND METHODS:A case-control study was conducted to investigate the role of these polymorph...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Delort L,Chalabi N,Satih S,Rabiau N,Kwiatkowski F,Bignon YJ,Bernard-Gallon DJ

    更新日期:2008-09-01 00:00:00

  • Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma.

    abstract:BACKGROUND:Biodegradable loaded systems are promising devices for controlled and sustained release of anticancer drugs to brain tumours. We investigated the influence of drug-release profiles of 5-fluorouracil-loaded microspheres designed for the treatment of malignant gliomas. MATERIALS AND METHODS:2.5 mg 5-FU delive...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Roullin VG,Lemaire L,Venier-Julienne MC,Faisant N,Franconi F,Benoit JP

    更新日期:2003-01-01 00:00:00

  • Modulation of innate immunological factors by STEALTH liposome-encapsulated tumor necrosis factor-alpha in a colon tumor xenograft model.

    abstract:BACKGROUND:Previous studies have shown that tumor necrosis factor-alpha (TNF-alpha) encapsulated in sterically-stabilized PEGylated STEALTH liposomes (SL) can better and more safely augment the efficacy of other treatment modalities than free TNF-alpha. The aim of this study was to examine the effects of SL-TNF-alpha i...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kim DW,Andres ML,Kajioka EH,Dutta-Roy R,Miller GM,Seynhaeve AL,ten Hagen TL,Gridley DS

    更新日期:2002-03-01 00:00:00

  • Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status.

    abstract:BACKGROUND:The phase II NEJ001 trial suggested that gefitinib was active against advanced non-small cell lung cancer (NSCLC) even in patients with poor performance status (PS). Clinical response among the patients harboring epidermal growth factor receptor (EGFR) mutation with poor PS is fair; however, gefitinib does n...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Okuma Y,Hosomi Y,Nagamata M,Yamada Y,Sekihara K,Kato K,Hishima T,Okamura T

    更新日期:2013-11-01 00:00:00

  • Development and prevention of metastasis.

    abstract::Metastatic spread of malignancy is the primary cause of treatment failure and subsequent death in cancer patients. All cancers have the capability to metastasize, however, there are notable exceptions which rarely if ever metastasize. These include basal cell carcinoma, or cancers which are primarily locally invasive ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Kohn EC

    更新日期:1993-11-01 00:00:00

  • Triptorelin (D-Trp-6-LHRH) in combination with carboplatin-containing polychemotherapy for advanced ovarian cancer: a pilot study.

    abstract::In experimental and clinical phase II trials GnRH agonists were shown to possess antitumor activity in ovarian cancer. The outcome of prostatic cancer was also improved experimentally by a combination of cytostatic chemotherapy and GnRH analogs. Encouraged by these results, we administered micro-encapsulated triptorel...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Medl M,Peters-Engel C,Fuchs G,Leodolter S

    更新日期:1993-11-01 00:00:00

  • Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.

    abstract::MicroRNAs (miRNA) are a class of small noncoding RNAs that regulate the expression of their target genes. The aim of the present study was to explore the effects of miR-206 on laryngeal suamous cell carcinoma (LSCC) cells. The expression level of miR-206 was quantified by qRT-PCR in primary LSCC tissues and correspond...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zhang T,Liu M,Wang C,Lin C,Sun Y,Jin D

    更新日期:2011-11-01 00:00:00

  • Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy.

    abstract:BACKGROUND/AIM:To identify the clinical and dosimetric predictors of severe acute radiation esophagitis (RE) in patients with non-small cell lung cancer (NSCLC) treated with accelerated hyperfractionated concurrent chemoradiotherapy (AH-CCRT) with concomitant boost technique. PATIENTS AND METHODS:A total of 159 patien...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13139

    authors: Wada K,Kishi N,Kanayama N,Hirata T,Ueda Y,Kawaguchi Y,Morimoto M,Konishi K,Imamura F,Ogawa K,Teshima T

    更新日期:2019-01-01 00:00:00

  • The protective effect of hochu-ekki-to (TJ-41), a Japanese herbal medicine, against HSV-1 infection in mitomycin C-treated mice.

    abstract:BACKGROUND:Immmunosuppression and infectious disease in cancer patients receiving chemotherapy is a serious problem. Immunopotentiating drugs may show a therapeutic efficacy. MATERIALS AND METHODS:The protective effect of Hochu-ekki-to (TJ-41), a Japanese traditional herbal medicine, on mitomycin C (MMC)-induced immun...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kido T,Mori K,Daikuhara H,Tsuchiya H,Ishige A,Sasaki H

    更新日期:2000-11-01 00:00:00

  • IL-8-251T>A (rs4073) Polymorphism Is Associated with Prognosis in Gastric Cancer Patients.

    abstract:BACKGROUND/AIM:Inflammation is a key process in gastric carcinogenesis. Cytokines are mediators of inflammation and are involved in metastasis and tumorigenicity. We previously assessed the role of cytokine gene polymorphisms in gastric cancer risk in Chile. In the present study, we aimed to analyze whether these polym...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12907

    authors: Gonzalez-Hormazabal P,Romero S,Musleh M,Bustamante M,Stambuk J,Pisano R,Lanzarini E,Chiong H,Rojas J,Castro VG,Jara L,Berger Z

    更新日期:2018-10-01 00:00:00

  • The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer.

    abstract:BACKGROUND:Dendritic cell (DC) mono-immunotherapy has not been successful so far in ovarian cancer. The addition of a toll-like receptor (TLR) agonist has the potential to boost the innate immune system, in addition to the adoptive immune response initiated by DCs. MATERIALS AND METHODS:ID8-fLuc C57BL/6 mice were inje...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11162

    authors: Vindevogel E,Baert T,VAN Hoylandt A,Verbist G,Vande Velde G,Garg AD,Agostinis P,Vergote I,Coosemans AN

    更新日期:2016-11-01 00:00:00

  • Successful gene transfer into dendritic cells with cationized gelatin and plasmid DNA complexes via a phagocytosis-dependent mechanism.

    abstract::The use of gene-modified dendritic cells (DC) is a powerful tool to enhance antitumor immune responses stimulated by these cells in cancer immunotherapy. Cationized gelatin is preferably incorporated via phagocytosis and is gradually degraded by proteolysis while buffering lysosomal activity. This may be appropriate f...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Inada S,Fujiwara H,Atsuji K,Takashima K,Araki Y,Kubota T,Tabata Y,Yamagishi H

    更新日期:2006-05-01 00:00:00

  • Microsatellite Instability Is Common in Colorectal Cancer in Native Nigerians.

    abstract:BACKGROUND:Colorectal cancer (CRC) is the fifth most common cancer in Africa, with significant differences in incidence, biology and clinical behavior from other populations. MATERIALS AND METHODS:We studied prevalence and clinicopathological features of microsatellite instability (MSI) and young onset CRC in 83 archi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11612

    authors: Irabor DO,Oluwasola OA,Ogunbiyi OJ,Ogun OG,Okolo CA,Melas M,Gruber SB,Shi C,Raskin L

    更新日期:2017-05-01 00:00:00

  • Cancer treatment of severely-III patients not eligible for chemotherapy.

    abstract:BACKGROUND:Despite having disseminated cancer, not all patients are eligible for palliative chemotherapy or targeted therapies. AIM:To study reasons for withholding palliative chemotherapy, to survey which alternatives were offered and to study survival outcomes. MATERIALS AND METHODS:Medical records of 346 patients ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Randén M,Runesdotter S,Strang P

    更新日期:2013-12-01 00:00:00